Tag Archives: CBD

NTRR: Huge Opportunities for Innovation Loom in Billion Dollar Cannabis Markets

By Business Wirevia The Motley Fool

Filed under:

NTRR: Huge Opportunities for Innovation Loom in Billion Dollar Cannabis Markets

SARASOTA, Fla.–(BUSINESS WIRE)– Even as lucrative new markets for medical marijuana continue to open up across North America, in many cases, patients don’t know much more about the cannabis they’re buying and consuming than the name of the strain. Neutra Corp. (OTCBB: NTRR) is exploring ways to change that.

Currently, the medical marijuana market in the U.S. is worth $1.7 billion. With more cannabis legislation now on the table from coast to coast, most industry experts agree that figure will rise. NTRR is looking for new technologies that will put the company on the cutting edge of cannabis-related products and services.

In order for patients to achieve consistent results with medical marijuana, they must know the potency of the drug’s active ingredients, including THC, cannabidiol (CBD) and cannabinol (CBN). This information would also allow state governments to regulate medicinal cannabis more effectively and let dispensaries differentiate products for pricing purposes.

Thanks to a boom in interest in medical marijuana, labs are popping up across the U.S. capable of delivering this important information. The laboratories with access to the most advanced technology for testing should capture a significant share of the testing market, says NTRR CEO Cindy Morrissey, because they’ll be better equipped to quickly and efficiently handle large volumes of cannabis.

“Patients use this crucial information to better predict how marijuana will help them, and to be sure that their marijuana is free of harmful pathogens, residue, pesticides and debris, which is important if you’re suffering from a serious illness,” she said. “Growers can use this lab data to monitor and upgrade their cultivation techniques. So, the market is there and growing for these testing innovations, and we’re seeking out potential partners who can help us deliver them.”

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (PINK: PHOT).

For more information on NTRR‘s initiatives, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information …read more
Source: FULL ARTICLE at DailyFinance

NTRR: $1.7 Billion Medical Marijuana Market Set to Explode as 'Green Rush' Gathers Steam

By Business Wirevia The Motley Fool

Filed under:

NTRR: $1.7 Billion Medical Marijuana Market Set to Explode as ‘Green Rush’ Gathers Steam

TAMPA, Fla.–(BUSINESS WIRE)– The incredible growth of the $142 billion global nutraceuticals industry has been driven by any number of medicinal herbs over the years, and that trend appears to be continuing in 2013. Neutra Corp. (OTCBB: NTRR) believes that the biggest story in nutraceuticals this year will stem from one of the world’s most popular medicinal herbs: Cannabis.

Medical marijuana is already big business. Prescription cannabis is now available in 18 states and Washington, D.C., with 11 more states considering legislation to legalize the drug for medical use. Currently, the medical marijuana market in the U.S. is worth $1.7 billion, with that figure expected to rise as more and more markets open up across the country.

For NTRR and other nutraceutical companies, the changing laws represent a huge opportunity.

“New technologies capable of extracting medically useful Cannabidoil (CBD) from cannabis and hemp are the future of nutraceuticals,” said NTRR CEO Cindy Morrissey. “CBD can be formulated into any number of existing, all-natural products and treatments, and there’s no question that demand for such products is sky-high and still growing.”

NTRR is seeking out new, emerging partners ready to develop and market innovations in the processing and use of cannabis-derived nutraceutical treatments for illnesses from cancer and arthritis to simple headaches and insomnia.

Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (NAS: CBIS) , Medical Marijuana Inc. (PINK: MJNA) and Terra Tech Corp. (NAS: TRTC) , enabling technological advancements in the cultivation and processing of cannabis in approved markets.

“This is a whole new industry, essentially, and the ‘green rush’ to capitalize is fully underway,” Morrissey said.

The company is also pursuing innovations in anti-microbial coatings for surfaces in hospitals and other public spaces. Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing wellness sector alongside Herbalife Ltd. (NYS: HLF) and Nutraceutical International Corp. (NAS: NUTR) .

For more information on NTRR‘s nutraceuticals initiative, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

…read more
Source: FULL ARTICLE at DailyFinance

Medical Marijuana Subsidiary PhytoSphere Outsources Oil Production

By Rich Smith, The Motley Fool

Filed under:

On Friday, one of the first public companies to try to capitalize on the marijuana legalization wave — aptly named Medical Marijuana, announced that its 80%-owned PhytoSPHERE Systems subsidiary has entered into a transaction with hemp-extract company CannaVEST.

Specifically, PhytoSPHERE is selling certain assets to CannaVEST for $35 million, payable in cash or CannaVEST stock in five quarterly installments beginning Jan. 31 and ending Dec. 31. The assets being sold include “equipment and inventory, Web domain names, phone numbers, and all existing and pending agreements with hemp production and processing facilities,” along with the grant of a license to use PhytoSPHERE brand names and logos.

The first installment payment, transferred on Jan. 29, shows how the agreement works in practice. CannaVEST issued 900,000 shares of stock, valued at $5 each, to PhytoSPHERE. PhytoSPHERE then transferred 720,000 of these shares to MM based on MM’s 80% ownership interest in PhytoSPHERE.

PhytoSPHERE explains the logic behind the transaction as “eliminating … substantial capital commitment required by our production facilities” by shifting raw material-production assets to CannaVEST. PhytoSPHERE maintains its access to hemp-based raw materials by entering into a supply agreement whereby CannaVEST will supply it with such ingredients at “high CBD concentrate hemp oil” needed to develop, manufacture, and market its products.

The article Medical Marijuana Subsidiary PhytoSphere Outsources Oil Production originally appeared on Fool.com.

Fool contributor Rich Smith and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
} else if (obj.attachEvent){
var r = obj.attachEvent("on"+evType, fn);
return r;
}
}

addEvent(window, "load", function(){new FoolVisualSciences();})
addEvent(window, "load", function(){new PickAd();})

var themeName = 'dailyfinance.com';
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-24928199-1']);
_gaq.push(['_trackPageview']);

(function () {

var ga = document.createElement('script');
ga.type = 'text/javascript';
ga.async = …read more
Source: FULL ARTICLE at DailyFinance